Want to see AU:VHL full AI Analyst Report?
VHL Stock Chart & Stats
AU$0.01
>-AU$0.01(-16.67%)
At close: 4:00 PM EDT
AU$0.01
>-AU$0.01(-16.67%)
Day’s Range― - ―
52-Week Range<AU$0.01 - AU$0.04
Previous CloseN/A
Volume4.82M
Average Volume (3M)1.81M
Market Cap
AU$35.23M
Enterprise ValueAU$18.32
Total Cash (Recent Filing)AU$3.06M
Total Debt (Recent Filing)AU$0.00
Price to Earnings (P/E)―
Beta1.48
Next Earnings
Mar 03, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding2,348,677,200
10 Day Avg. Volume706,842
30 Day Avg. Volume1,813,321
Financial Highlights & Ratios
PEG Ratio0.11
Price to Book (P/B)1.25
Price to Sales (P/S)4.73
P/FCF Ratio-2.02
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)>-0.01
Revenue Forecast (FY)AU$11.80M
Bulls Say, Bears Say
Bulls Say
Strong Revenue GrowthRapid annual revenue growth indicates improving commercial traction and expanding demand. If sustained, this scale can strengthen the operating model and create a larger base from which the company may eventually improve margins.
Debt-free Balance SheetZero debt limits interest obligations and refinancing exposure, while the substantial equity base provides some flexibility to fund operations. This gives the company greater financial resilience than a similarly loss-making, highly leveraged peer.
Positive EPS Growth TrendPositive reported EPS growth suggests some improvement in per-share performance despite the company remaining unprofitable. Sustained progress could support eventual earnings normalization, although the current loss profile means this benefit remains early-stage.
Bears Say
Severely Weak ProfitabilityCosts exceeding revenue at the gross-profit level indicate the business is not yet covering direct operating expenses. Deep losses across EBITDA, EBIT, and net income weaken internal funding capacity and show that scalable economics have not been established.
Persistent Cash BurnMaterial recurring cash outflows can force reliance on external capital to maintain operations and invest in growth. Unless cash conversion improves, funding needs may constrain strategy, increase execution risk, and reduce financial flexibility.
Risk Of Future DilutionA debt-free structure does not eliminate financing risk when losses and cash consumption continue. If external equity funding is required, additional issuance could dilute existing holders and signal that the current business model remains dependent on capital support.
Vitasora Health News
VHL FAQ
What was Vitasora Health’s price range in the past 12 months?
Vitasora Health lowest share price was <AU$0.01 and its highest was AU$0.04 in the past 12 months.
What is Vitasora Health’s market cap?
Vitasora Health’s market cap is AU$35.23M.
When is Vitasora Health’s upcoming earnings report date?
Vitasora Health’s upcoming earnings report date is Mar 03, 2027 which is in 177 days.
How were Vitasora Health’s earnings last quarter?
Vitasora Health released its earnings results on Aug 28, 2026. The company reported -AU$0.003 earnings per share for the quarter, missing the consensus estimate of -AU$0.002 by -AU$0.001.
Is Vitasora Health overvalued?
According to Wall Street analysts Vitasora Health’s price is currently Overvalued.
Does Vitasora Health pay dividends?
Vitasora Health does not currently pay dividends.
What is Vitasora Health’s EPS estimate?
Vitasora Health’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Vitasora Health have?
Vitasora Health has 2,348,677,200 shares outstanding.
What happened to Vitasora Health’s price movement after its last earnings report?
Vitasora Health reported an EPS of -AU$0.003 in its last earnings report, missing expectations of -AU$0.002. Following the earnings report the stock price went up 7.143%.
Which hedge fund is a major shareholder of Vitasora Health?
Currently, no hedge funds are holding shares in AU:VHL
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Vitasora Health Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
AU:VHL Sentiment 83%
Sector Average 60%
Sector Average 60%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
8.23%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Vitasora Health
Headquartered in Melbourne, Australia, Vitasora Health Limited specializes in the research, development, and market introduction of medical devices across Australia and the United States. The company's portfolio also includes the creation of mobile health applications. Notably, the firm, previously known as Respiri Limited, officially rebranded as Vitasora Health Limited in April 2025.
Technical Analysis
Oneview Healthcare Chess Depository Interests repr 1
―
Mach7 Technologies
―
Beamtree Holdings Ltd
―
Alcidion Group Limited
―
PainChek Ltd
―